BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1595513)

  • 1. Intensive insulin therapy: Part II. Multicomponent insulin regimens.
    Hirsch IB; Herter CD
    Am Fam Physician; 1992 Jun; 45(6):2643-8. PubMed ID: 1595513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New methods in insulin treatment].
    Neuwirth G
    Orv Hetil; 2005 Jan; 146(3):111-6. PubMed ID: 15693442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term.
    Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections.
    Meneghini L; Sparrow-Bodenmiller J
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S109-14. PubMed ID: 20515298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic agents.
    Francisco GE
    Prim Care; 1990 Sep; 17(3):499-519. PubMed ID: 2236334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin glargine: a new once-daily basal insulin for the management of type 1 and type 2 diabetes mellitus.
    Lam S
    Heart Dis; 2003; 5(3):231-40. PubMed ID: 12783637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin glargine (Lantus).
    Owens DR; Griffiths S
    Int J Clin Pract; 2002; 56(6):460-6. PubMed ID: 12166545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy.
    Rizza RA; Gerich JE; Haymond MW; Westland RE; Hall LD; Clemens AH; Service FJ
    N Engl J Med; 1980 Dec; 303(23):1313-8. PubMed ID: 7001229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin strategies for managing inpatient and outpatient hyperglycemia and diabetes.
    Moghissi ES
    Mt Sinai J Med; 2008 Dec; 75(6):558-66. PubMed ID: 19021195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical strategies for controlling peaks and valleys: type 1 diabetes.
    Bolli GB
    Int J Clin Pract Suppl; 2002 Jul; (129):65-74. PubMed ID: 12166610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive insulin treatment in diabetic children.
    Ludvigsson J; Bolli GB
    Diabetes Nutr Metab; 2001 Oct; 14(5):292-304. PubMed ID: 11806471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of diabetes in the hospital.
    Fonseca V
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S10-7. PubMed ID: 17224872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of insulin-dependent diabetes using an injection pen: control, problems and patient preferences.
    Fisken RA; Goulbourn J
    Diabetes Res; 1989 Aug; 11(4):195-7. PubMed ID: 2696619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
    Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
    Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol.
    Shulman R; Finney SJ; O'Sullivan C; Glynne PA; Greene R
    Crit Care; 2007; 11(4):R75. PubMed ID: 17623086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of injection techniques for soluble and protamine zinc insulins in diabetes mellitus.
    Harrower AD; Duncan LJ; Clarke BF
    Practitioner; 1975 Feb; 214(1280):228-31. PubMed ID: 1144249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system.
    Pickup JC; Viberti GC; Keen H; Parsons JA; Alberti KG
    Horm Metab Res Suppl; 1979; (8):202-4. PubMed ID: 395081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.